Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The future of immune checkpoint blockade immunotherapy: towards personalized therapy or towards combination therapy.

Literature DB >> 29268478

The future of immune checkpoint blockade immunotherapy: towards personalized therapy or towards combination therapy.

Zhiwei Hu¹.

Abstract

Year: 2017 PMID： 29268478 PMCID： PMC5721014 DOI： 10.21037/jtd.2017.10.31

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

× No keyword cloud information.

25 in total

1. Effective treatment of human lung cancer by targeting tissue factor with a factor VII-targeted photodynamic therapy.

Authors: J Cheng; J Xu; J Duanmu; H Zhou; C J Booth; Z Hu
Journal: Curr Cancer Drug Targets Date: 2011-11 Impact factor: 3.428

Review 2. Natural killer cell adoptive immunotherapy: Coming of age.

Authors: Letícia Baggio; Álvaro Macedo Laureano; Lucia Mariano da Rocha Silla; Dean Anthony Lee
Journal: Clin Immunol Date: 2016-02-14 Impact factor: 3.969

3. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.

Authors: Z Hu; A Garen
Journal: Proc Natl Acad Sci U S A Date: 2001-10-02 Impact factor: 11.205

4. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.

Authors: Mark Ayers; Jared Lunceford; Michael Nebozhyn; Erin Murphy; Andrey Loboda; David R Kaufman; Andrew Albright; Jonathan D Cheng; S Peter Kang; Veena Shankaran; Sarina A Piha-Paul; Jennifer Yearley; Tanguy Y Seiwert; Antoni Ribas; Terrill K McClanahan
Journal: J Clin Invest Date: 2017-06-26 Impact factor: 14.808

5. Systemic Immunity Is Required for Effective Cancer Immunotherapy.

Authors: Matthew H Spitzer; Yaron Carmi; Nathan E Reticker-Flynn; Serena S Kwek; Deepthi Madhireddy; Maria M Martins; Pier Federico Gherardini; Tyler R Prestwood; Jonathan Chabon; Sean C Bendall; Lawrence Fong; Garry P Nolan; Edgar G Engleman
Journal: Cell Date: 2017-01-19 Impact factor: 41.582

6. Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.

Authors: Haidong Tang; Yang Wang; Lukasz K Chlewicki; Yuan Zhang; Jingya Guo; Wei Liang; Jieyi Wang; Xiaoxiao Wang; Yang-Xin Fu
Journal: Cancer Cell Date: 2016-03-14 Impact factor: 31.743

7. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease.

Authors: J Contrino; G Hair; D L Kreutzer; F R Rickles
Journal: Nat Med Date: 1996-02 Impact factor: 53.440

8. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.

Authors: J Duanmu; J Cheng; J Xu; C J Booth; Z Hu
Journal: Br J Cancer Date: 2011-03-22 Impact factor: 7.640

9. PD-1 blockade induces responses by inhibiting adaptive immune resistance.

Authors: Paul C Tumeh; Christina L Harview; Jennifer H Yearley; I Peter Shintaku; Emma J M Taylor; Lidia Robert; Bartosz Chmielowski; Marko Spasic; Gina Henry; Voicu Ciobanu; Alisha N West; Manuel Carmona; Christine Kivork; Elizabeth Seja; Grace Cherry; Antonio J Gutierrez; Tristan R Grogan; Christine Mateus; Gorana Tomasic; John A Glaspy; Ryan O Emerson; Harlan Robins; Robert H Pierce; David A Elashoff; Caroline Robert; Antoni Ribas
Journal: Nature Date: 2014-11-27 Impact factor: 49.962

Review 3. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.

Authors: Ruixue Huang; Ping-Kun Zhou
Journal: Signal Transduct Target Ther Date: 2021-07-09

3 in total